Using muscle relaxants to improve electroporation ablation safety
Official title: The Use of Muscle Relaxants During Electroporation Ablation (PFA) as a Potential Protective Factor Against Damage to Transverse Striated Muscle Tissue and the Heart
Run by 4th Military Clinical Hospital with Polyclinic, Poland · NCT06707532 · Data updated 2026-11-12
This study tests if using muscle relaxants during a heart procedure called electroporation ablation can make it safer for patients and help them recover faster.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | 4th Military Clinical Hospital with Polyclinic, Poland Academic / other |
| Locations | 1 site (Wroclaw, Lower Silesian Voivodeship) |
| Status | Recruiting |
| Started | August 1, 2024 |
| Main results expected | December 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | November 27, 2024 |
| Trial ID | NCT06707532 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients requiring PFA ablation for cardiac indications who can provide informed consent.
✕Probably not a fit
Patients with allergies to the anesthetics used or genetic neuromuscular diseases will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the use of muscle relaxants during electroporation ablation (PFA) to enhance patient safety by minimizing skeletal muscle damage and assessing myocardial damage. Patients will be randomized into two groups: one receiving general anesthesia without muscle relaxants and the other with rocuronium. The study aims to improve the quality of the PFA procedure and accelerate recovery times. A total of 32 patients will participate, with a double-blind design to ensure unbiased results.
Why it matters
Potential benefit: If successful, this approach could lead to safer and more effective electroporation ablation procedures for patients with cardiac conditions.
How similar studies have gone: While the use of muscle relaxants in similar procedures has been explored, this specific application in electroporation ablation is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with requirement for PFA ablation for cardiac indications and ability to provide informed consent for study participation Exclusion Criteria: * Patients with allergies to the general anaesthetics used, genetic diseases of the neuromuscular plateau - e.g. Duchenne dystrophy, myasthenia gravis - and patients who do not gived informed consent to participate in the study will be excluded from the study.
Where it's running
-
4th Military Clinical Hospital with Polyclinic
Wroclaw, Lower Silesian Voivodeship, Poland Recruiting
Study contacts
- Principal investigator: Marek Szamborski, MD — Senior Assistant
- Study coordinator: Marek Szamborski, MD
- Email: mszamborski@4wsk.pl
- Phone: 698-448-639
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Natural history documentation of TNNT1 myopathy
This study is trying to learn more about how TNNT1 myopathy affects people over time to help improve future treatments.
-
Propofol-Ketamine vs Sevoflurane for anesthesia in kids undergoing heart catheterization
In children needing a heart catheterization, doctors compare using propofol-ketamine versus sevoflurane to see which anesthesia approach is safer and helps kids wake up smoothly.
-
Imaging markers for bulbar involvement in inclusion body myositis among IBM and comparison groups
This study tests whether ultrasound and MRI can detect swallowing and bulbar muscle problems in people with inclusion body myositis.
-
Measuring muscle health with a handheld electrical impedance device (mScan)
This project will test whether a handheld mScan device can quickly measure muscle health in adults with myopathies and in people without muscle disease by comparing its readings to MRI.
-
Which pre‑induction medicine causes less coughing: tegilidine or sufentanil
This will see if tegilidine or sufentanil causes less coughing when given before general anesthesia in adults having planned tracheal intubation.
-
Predicting low blood pressure after anesthesia in older adults using carotid cFT and IVC collapsibility
We will test whether two ultrasound measurements—carotid corrected flow time (cFT) and the inferior vena cava (IVC) collapsibility index—can predict which older adults having elective surgery will develop low blood pressure after induction of general anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.